López-Fernández Silvia, Cequier Angel, Iràculis Emili, Gómez-Hospital Joan A, Teruel Luis, Valero José, Beltrán Paola, García del Blanco Bruno, Jara Francesc, Esplugas Enric
Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital Universitario de Bellvitge, Universidad de Barcelona, L'Hospitalet de Llobregat, Barcelon,. Spain.
Rev Esp Cardiol. 2004 Apr;57(4):291-8.
The prognosis in patients with acute coronary syndrome without persistent ST segment elevation (NSTEACS) differs depending on cardiac troponin levels. Clinical practice guidelines published by the Spanish Society of Cardiology and the ACC/AHA consider patients with NSTEACS and markedly elevated troponin levels as high risk patients. The aim of this study was to identify factors related to markedly elevated troponin I levels in NSTEACS.
We measured troponin I levels in 219 consecutive patients with NSTEACS and normal CK-MB values, and identified 2 groups: patients with markedly elevated troponin levels (more than 10-fold the normal upper limit), and patients with normal or slightly elevated troponin levels (less than a 10-fold increase above the normal limit). We also analyzed clinical and angiographic variables. Logistic regression was used to calculate age- and sex-adjusted associations for the main variables.
Forty-one patients (19%) had markedly elevated troponin levels, and 178 (81%) showed normal or slightly elevated troponin I levels. Patients with markedly elevated levels had more frequently prolonged angina, class IIb angina, more severe ECG changes, a higher number of diseased vessels on coronary angiography, and greater severity of the culprit lesion. The culprit stenosis in these patients was more often characterized as ulcerated, showing visible thrombus, and excentric, bifurcated and irregular. Class IIIb angina (odds ratio [OR] = 3.1; CI 95%, 1.1-8.6), bifurcation (OR=6.04; CI 95%, 2.5-14.3), ulceration (OR=3.2; CI 95%, 1.07-9.7) and visible thrombus (OR=2.7; CI 95%, 1.1-6.3) in the culprit lesion were predictive factors associated with markedly elevated levels of troponin I independently of age or sex.
Markedly elevated troponin I levels in patients with NSTEACS are associated with a more severe clinical presentation and increased complexity of the culprit lesion on coronary angiography.
非持续性ST段抬高型急性冠状动脉综合征(NSTEACS)患者的预后因心肌肌钙蛋白水平而异。西班牙心脏病学会和美国心脏病学会/美国心脏协会发布的临床实践指南将NSTEACS且肌钙蛋白水平显著升高的患者视为高危患者。本研究的目的是确定与NSTEACS患者肌钙蛋白I水平显著升高相关的因素。
我们测量了219例连续的NSTEACS且CK-MB值正常患者的肌钙蛋白I水平,并将其分为两组:肌钙蛋白水平显著升高组(超过正常上限的10倍)和肌钙蛋白水平正常或轻度升高组(比正常上限升高不足10倍)。我们还分析了临床和血管造影变量。采用逻辑回归计算主要变量的年龄和性别调整后的关联。
41例患者(19%)肌钙蛋白水平显著升高,178例(81%)肌钙蛋白I水平正常或轻度升高。肌钙蛋白水平显著升高的患者更常出现心绞痛持续时间延长、IIb级心绞痛、更严重的心电图改变、冠状动脉造影显示病变血管数量更多以及罪犯病变更严重。这些患者的罪犯狭窄更常表现为溃疡、可见血栓、偏心、分叉和不规则。罪犯病变中的IIIb级心绞痛(比值比[OR]=3.1;95%可信区间,1.1 - 8.6)、分叉(OR = 6.04;95%可信区间,2.5 - 14.3)、溃疡(OR = 3.2;95%可信区间,1.07 - 9.7)和可见血栓(OR = 2.7;95%可信区间,1.1 - 6.3)是与肌钙蛋白I水平显著升高相关的独立于年龄或性别的预测因素。
NSTEACS患者肌钙蛋白I水平显著升高与更严重的临床表现以及冠状动脉造影显示的罪犯病变复杂性增加相关。